國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Translating molecules into medicines...

Bhattachar, Shobha N.

Translating molecules into medicinescross-functional integration at the drug discovery-development interface /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Translating molecules into medicinesedited by Shobha N. Bhattachar ... [et al.].
其他題名:	cross-functional integration at the drug discovery-development interface /
其他作者:	Bhattachar, Shobha N.
出版者:	Cham :Springer International Publishing :2017.
面頁冊數:	xxiv, 461 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
標題:	Drug development.
電子資源:	http://dx.doi.org/10.1007/978-3-319-50042-3
ISBN:	9783319500423$q(electronic bk.)

Translating molecules into medicinescross-functional integration at the drug discovery-development interface /
Translating molecules into medicinescross-functional integration at the drug discovery-development interface /[electronic resource] :edited by Shobha N. Bhattachar ... [et al.]. - Cham :Springer International Publishing :2017. - xxiv, 461 p. :ill. (some col.), digital ;24 cm. - AAPS advances in the pharmaceutical sciences series,v.252210-7371 ;. - AAPS advances in the pharmaceutical sciences series ;3..

Tackling translational medicine with a focus on the drug discovery development-interface, this book integrates approaches and tactics from multiple disciplines, rather than just the pharmaceutical aspect of the field. The authors of each chapter address the paradox between the molecular understanding of diseases, drug discovery, and drug development. Laying out the detailed trends from various fields, different chapters are dedicated to target engagement, toxicological safety assessments, and the compelling relationship of optimizing early clinical studies with design strategies. The book also highlights the importance of balancing the three pillars: sufficient efficacy, acceptable safety and appropriate pharmacokinetics, all of which are crucial to successful efforts in discovery and development. With discussions regarding the combined approaches of molecular research, personalized medicine, pre-clinical and clinical development, as well as targeted therapies--this compendium is a flexible fit, perfect for professionals in the pharmaceutical industry and related academic fields.

ISBN: 9783319500423$q(electronic bk.)

Standard No.: 10.1007/978-3-319-50042-3doiSubjects--Topical Terms:

190608
Drug development.

LC Class. No.: RM301.25

Dewey Class. No.: 615.19

Translating molecules into medicinescross-functional integration at the drug discovery-development interface /
LDR:02204nmm a2200313 a 4500 001 511783
003 DE-He213
005 20170421151030.0
006 m d
007 cr nn 008maaau
008 171226s2017 gw s 0 eng d
020 $a 9783319500423$q(electronic bk.)
020 $a 9783319500409$q(paper)
024 7 $a 10.1007/978-3-319-50042-3 $2 doi
035 $a 978-3-319-50042-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.25
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
082 0 4 $a 615.19 $2 23
090 $a RM301.25 $b .T772 2017
245 0 0 $a Translating molecules into medicines $h [electronic resource] : $b cross-functional integration at the drug discovery-development interface / $c edited by Shobha N. Bhattachar ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a xxiv, 461 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a AAPS advances in the pharmaceutical sciences series, $x 2210-7371 ; $v v.25
520 $a Tackling translational medicine with a focus on the drug discovery development-interface, this book integrates approaches and tactics from multiple disciplines, rather than just the pharmaceutical aspect of the field. The authors of each chapter address the paradox between the molecular understanding of diseases, drug discovery, and drug development. Laying out the detailed trends from various fields, different chapters are dedicated to target engagement, toxicological safety assessments, and the compelling relationship of optimizing early clinical studies with design strategies. The book also highlights the importance of balancing the three pillars: sufficient efficacy, acceptable safety and appropriate pharmacokinetics, all of which are crucial to successful efforts in discovery and development. With discussions regarding the combined approaches of molecular research, personalized medicine, pre-clinical and clinical development, as well as targeted therapies--this compendium is a flexible fit, perfect for professionals in the pharmaceutical industry and related academic fields.
650 0 $a Drug development. $3 190608
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
700 1 $a Bhattachar, Shobha N. $3 779252
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a AAPS advances in the pharmaceutical sciences series ; $v 3. $3 559046
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-50042-3
950 $a Biomedical and Life Sciences (Springer-11642)